Administration of Methylprednisolone for Prevention of Ovarian Hyper Stimulation Syndrome in In-vitro Fertilization Cycles: A Randomized Controlled Trial.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Methylprednisolone (Primary)
- Indications Ovarian hyperstimulation syndrome
- Focus Therapeutic Use
Most Recent Events
- 25 Aug 2011 New source identified and integrated (Iranian Registry of Clinical Trials; IRCT138806181141N6).
- 18 Jul 2011 Actual patient number is 218 as reported by ClinicalTrials.gov.
- 15 Jul 2011 Biomarkers information updated